NewAmsterdam Pharma

$NewAmsterdam Pharma(NAMS)$ 建仓，看好能在AD上弄出些大动静来

#药闻简讯# $NewAmsterdam Pharma(NAMS)$ 宣布已接受 EMA 对 Obicetrapib 的上市许可申请进行审查

#药闻简讯# 2025年8月6日, $NewAmsterdam Pharma(NAMS)$ 今日公布了截至2025年6月30日的季度财务业绩，并提供了公司最新动态。该公司是一家处于临床后期阶段的生物制药企业，专注于为低密度脂蛋白胆固醇（"LDL-C"）升高、现有疗法疗效不足或耐受性不佳的心血管疾病（"CVD"）高危患...

$NewAmsterdam Pharma(NAMS)$ 兄弟们有懂图形的么 看看这个股的走势怎么说呗

Baxdrostat和Obicetrapib应该是未来5年高血压和降血脂领域最有药物经济学价值的两个小分子了 难得的低风险中高收益的品种 我认为未来10年慢病管理领域始终还是小分子的天下
$NewAmsterdam Pharma(NAMS)$

NewAmsterdam Pharma$NewAmsterdam Pharma(NAMS)$ 2025年8月18日宣布，欧洲药品管理局（EMA）已正式接受其降脂药物obicetrapib新药上市申请（MAA），用于治疗原发性高胆固醇血症或混合性血脂异常患者。
主要关键III期临床试验（BROADWAY、TANDEM和BROOKLYN）数据显示，obicetrapib单药能够降低...

$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001422849-25-000040  Act: 34  Size: 7 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0000950170-25-109387  Act: 34  Size: 209 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-103520  Act: 34  Size: 834 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-096665  Size: 16 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0000950170-25-112345  Act: 34  Size: 18 MB 网页链接

$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0001974494-25-000102  Act: 33  Size: 5 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0002004379-25-000002  Act: 33  Size: 4 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-225170  Act: 34  Size: 205 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-103521  Act: 34  Size: 8 MB 网页链接

$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000950170-25-107390  Act: 34  Size: 145 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0002056296-25-000009  Act: 33  Size: 5 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-113276  Size: 4 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-114033  Size: 10 KB 网页链接

$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0001969223-25-000508  Act: 33  Size: 5 KB 网页链接